Ionis Pharmaceuticals (IONS) PT Lowered to $45 at Piper Sandler
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $40.78 -0.61%
Rating Summary:
8 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Rating Summary:
8 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Trade Now!
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Piper Sandler analyst Tyler Van Buren lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $45.00 (from $55.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlueScope Steel Limited (BSL:AU) (BLSFY) PT Raised to AUD22.50 at Credit Suisse
- Movida Participacoes SA (MOVI3:BZ) PT Lowered to R$20 at Morgan Stanley
- Hana Financial Group (086790:KS) PT Raised to KRW51,000 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
